US Stocks
/
SCYNEXIS, Inc. Share Price
SCYNEXIS, Inc. Share Price

SCYNEXIS, Inc. Share Price

NASDAQ: SCYX | Micro Cap
$4.06
-$0.13 (-3.1%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

SCYNEXIS, Inc. Stock Performance

Open
$4.21
Prev. Close
$4.19
Circuit Range
N/A
Day Range
$4.06 - $4.21
Year Range
$0.57 - $6.01
Volume
933
Average Traded
$4.16

SCYNEXIS, Inc. Share Price Today

As of 10 October 2026, SCYNEXIS, Inc.'s share price is $4.06. The stock opened at $4.21, compared to its previous close of $4.19. During today's trading session, SCYNEXIS, Inc.'s share price traded between $4.06 and $4.21, with an average price of $4.13. Over the past 52 weeks, the stock has recorded a high of $6.01 and a low of $0.57. In terms of performance, SCYNEXIS, Inc.'s share price has risen by 335.16% over the last six months and is up 515.15% on a year-on-year basis.

SCYNEXIS, Inc. Share Price Chart

$4.06$4.21
L
Show Current Price
H

SCYNEXIS, Inc. Stock Fundamentals & Key Indicators

Market Cap
$202.73M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.03
Revenue (TTM)
$20.60B
Return On Equity (TTM)
-15.29%
Profit Margin
-41.80%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
186.15%

SCYNEXIS, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.33$18.65$0.00$0.24
Net Profit-$8.59$12.26-$21.30$7.40
Net Profit Margin-2603.03%65.74%N/A3083.33%
Income ChangeN/A242.72%-273.74%134.74%

SCYNEXIS, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.09$140.14$3.75$20.60
Net Profit-$62.81$67.04-$21.29-$8.61
Net Profit Margin-1233.99%47.84%-567.73%-41.80%
Income ChangeN/A206.73%-131.76%59.56%

About SCYNEXIS, Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

SCYNEXIS, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$5.14
$4.06
-18.17%
Sep 2026
$5.25
$4.96
-9.82%
Aug 2026
$4.81
$5.50
+12.47%
Jul 2026
$4.13
$4.89
+20.62%
Jun 2026
$5.26
$4.05
+471.79%
May 2026
$0.94
$0.71
-24.01%
Apr 2026
$0.89
$0.93
+2.53%
Mar 2026
$0.74
$0.91
+22.15%
Feb 2026
$0.70
$0.74
+4.78%
Jan 2026
$0.63
$0.71
+13.94%
Dec 2025
$0.67
$0.62
-11.74%
Nov 2025
$0.64
$0.71
+7.12%

SCYX Share Price FAQs

What is SCYNEXIS, Inc. share price today?

chevron-up
SCYNEXIS, Inc. share price today is $4.06 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of SCYNEXIS, Inc. stock?

chevron-up
The 52 week high of SCYNEXIS, Inc. stock is $6.01, while the 52 week low is $0.57 as of 10 Oct '26.

What is SCYX's market capitalisation today?

chevron-up
SCYX market capitalisation is $202.73M as of October 10, 2026, at 4:42 am IST.

What is SCYX's net income for the last quarter?

chevron-up
SCYX's net income for the last quarter is 7.40B USD.

What is the 5 year returns of SCYX?

chevron-up
The 5 year returns of SCYX is -18.96% as on 10 Oct '26.

What is the high & low stock price of SCYX today?

chevron-up
SCYX stock price hit a high of $4.21 and low of $4.06 as of 10 Oct '26.

Can I buy SCYX shares in India?

chevron-up
Yes. You can buy SCYX in India by opening an international trading account.